Item 8.01 Other Events

On August 24, 2009, Cambrex Corporation issued a press release in which it announced that it had received a warning letter from the U.S. Food and Drug Administration ("FDA") in connection with the FDA's March 2009 inspection of Cambrex's manufacturing facility in Milan, Italy. A copy of the press release is attached as Exhibit 99.1 to this Form 8-K and is hereby incorporated by reference.

Item 9.01 - Financial Statements and Exhibits

(c) Exhibits

(99.1) Press Release of Cambrex Corporation dated August 24, 2009

---